Meet your researcher – Andrew Marshall

Published on
8 April 2024
Andrew Marshall

Andrew Marshall is a Foundation-funded postdoctoral academic at the University of Tasmania, pioneering neonatal care research to improve preterm infants' outcomes.

What made you want to get into medical research?

My passion for medical research was ignited during my Bachelor of Engineering's final year, where I designed an automated oxygen delivery system for preterm infants. This blend of engineering and healthcare captivated me, and I was inspired to pursue a PhD on this topic, leading to its clinical evaluation at the Royal Hobart Hospital and worldwide commercialisation. I now continue this research as a postdoctoral academic at the University of Tasmania.

What is the most rewarding thing about being a medical researcher in Tasmania?

In Tasmania, the close-knit nature of our community fosters unique collaborations, notably between the School of Engineering, Menzies Institute for Medical Research, and Royal Hobart Hospital Neonatal and Paediatric Intensive Care Unit (NPICU). Being embraced by the NPICU family and seeing our research benefit vulnerable infants offers immense satisfaction, underscoring the impact of our work on real-world patient outcomes.

How has the funding of the Royal Hobart Hospital Research Foundation helped you achieve your research goals?

The Foundation's grants have been crucial, supporting the development of innovative sensors and therapeutic interventions. This funding has enabled our team to conduct clinical studies and gather unique information, enhancing our efforts to monitor and treat upper airway obstructions in preterm infants. These advancements aim to significantly improve patient outcomes and broaden our research into preterm babies with breathing difficulties known as apnoea.

What research project do you have planned next?

Our upcoming research encompasses two main themes: refining our automated oxygen control system for broader application; and advancing the prediction, detection, and treatment of apnoea with new sensors, systems, and intervention methods. These initiatives are designed to elevate neonatal care across various settings, demonstrating our dedication to improving newborn health.

Your generosity fuels the groundbreaking work of medical researchers like Andrew, making a real difference in the lives of Tasmanians. Help us keep supporting the future of medical research in our community. Donate today online or call us at (03) 6166 1319.